Mechanism of immune-mediated skin diseases: An overview

Clinical and Experimental Rheumatology

Volumn 24, Issue SUPPL. 40, 2006, Pages

  Beissert, S ^a   Cavazzana, I ^b   Mascia, F ^c   Meroni, P ^d   Pastore, S ^c   Tessari, G ^e   Girolomoni, Giampiero ^e  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF BRESCIA   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF VERONA   (Italy)

Author keywords

Anti endothelial cell antibodies; Anti fibroblast antibodies; Anti Ro SSA antibodies; Atopic dermatitis; Keratinocytes; Skin; Systemic lupus erythematosus; Systemic sclerosis; T regulatory cells

Indexed keywords

AUTOANTIBODY; CD40 LIGAND; CHEMOKINE; CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RO ANTIBODY; CD40 ANTIGEN;

ANTIGEN SPECIFICITY; ATOPIC DERMATITIS; AUTOIMMUNE SKIN DISEASE; DERMIS; DRUG TARGETING; ENDOTHELIUM CELL; EPIDERMIS; FIBROBLAST; GENETIC PREDISPOSITION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SKIN MANIFESTATION; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; AUTOIMMUNE DISEASE; CHRONIC DISEASE; DERMATITIS; IMMUNOLOGY; SKIN DISEASE; T LYMPHOCYTE;

ANTIGENS, CD40; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CD40 LIGAND; CHRONIC DISEASE; DERMATITIS; HUMANS; KERATINOCYTES; SKIN DISEASES; T-LYMPHOCYTES;

EID: 33645032153     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. BOS JD (Ed.): Skin Immune System. Cutaneous Immunology and Clinical Immunodermatology. 3rd ed., Boca Raton, FL, CRC Press 2005.
2. GIROLOMONI G, La SALA A: Dendritic cells (T-lymphocyte stimulating). In: Encyclopedia of Life Science. Wiley Interscience. www.els.net. 2005
3. BANCHEREAU J, STEINMAN RM: Dendritic cells and the control of immunity. Nature 1998; 392: 245-52.
4. MEHLING A, LOSER K, VARGA G et al.: Over-expression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med 2001; 194: 615-28.
5. GERSHON RK, COHEN P, HENCIN R, LIEBHABER SA: Suppressor T cells. J Immunol 1972; 108: 586-90.
6. SAKAGUCHI S, SAKAGUCHI N, ASANO M, ITOH M, TODA M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64.
7. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182: 18-32.
8. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389-400.
9. + immunoregulatory T cells. J Exp Med 2001; 194: 427-38.
10. + regulatory T cells: thymus or periphery. J Clin Invest 2003; 112: 1310-2.
11. high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenim effector T cell proliferation. J Immunol 2005; 174: 164-73.
12. + regulatory T cells maintain immune tolerance to nickel in healthy, non allergic individuals. J Immunol 2003; 171: 5760-8.
13. HERTL M, VELDMAN C: T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skin. Autoimmun Rev 2003; 2: 278-83.
14. ALBANESI C, SCARPONI C, GIUSTIZIERI ML, GIROLOMONI G: Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 2005; 4: 329-34.
15. PASTORE S, FANALES-BELASIO E, ALBANESI C, CHINNI ML, GIANNETTI A, GIROLOMONI G: Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 1997; 99: 3009-12.
16. PASTORE S, MASCIA F, MARIOTTI F, DATTILO C, GIROLOMONI G: Chemokine networks in inflammatory skin diseases. Eur J Dermatol 2004; 14: 203-8.
17. CAVANI A, ALBANESI C, TRAIDL C, SEBASTIANI S, GIROLOMONI G: Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol 2001; 22: 118-20.
18. PASTORE S, CORINTI S, LA PLACA M, DIDONA B, GIROLOMONI G: Interferon-γ promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. J Allergy Clin Immunol 1998; 101: 538-44.
19. PASTORE S, GIUSTIZIERI ML, MASCIA F, GIANNETTI A, KAUSHANSKY K, GIROLOMONI G: Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor. J Invest Dermatol 2000; 115: 1134-43.
20. GIUSTIZIERI ML, MASCIA F, FREZZOLINI A et al.: Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001; 107: 871-7.
21. GIUSTIZIERI ML, ALBANESI C, SCARPONI C, DE PITÀ O, GIROLOMONI G: Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo. Am J Pathol 2002; 161: 1409-18.
22. McKENZIE RC, SABIN E: Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis. Exp Dermatol 2003; 12: 337-45.
23. COLOTTA F, RE F, MUZIO M et al.: Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472-5.
24. MASCIA F, MARIANI V, GIROLOMONI G, PASTORE S: Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol 2003; 163: 303-12.
25. PASTORE S, MASCIA F, MARIOTTI F, DATTILO C, MARIANI V, GIROLOMONI G: ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 2005; 174: 5047-56.
26. PARKS W, WILSON CL, LÒPEZ-BOADO YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004; 4: 617-29.
27. CHIZZOLINI C, RASCHI E, REZZONICO R et al.: Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 2002; 46: 1602-13.
28. RONDA N, GATTI R, GIACOSA R et al.: Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway. Arthritis Rheum 2002; 46: 1595-601.
29. HENAULT J, TREMBLAY M, CLEMENT I, RAYMOND Y, SENECAL JL: Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 2004; 50: 3265-74.
30. WORDA M, SGONC R, DIETRICH H et al.: In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorioanallantoic membrane assay. Arthritis Rheum 2003; 48: 2605-14.
31. MERONI PL, RONDA N, RASCHI E, BORGHI MO: Humoral autoimmunity against endothelium: theory or reality ? Trends Immunol 2005; 26: 275-81.
32. FRANCESCHINI F, CAVAZZANA I: Anti-Ro/SSA and La/SSB antibodies. Autoimmunity 2005; 38: 55-63.
33. BERNACCHI E, AMATO L, PARODI A et al.: Sjögren's syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin Exp Rheumatol 2004; 22: 55-62.
34. LEE LA, GAITHER KK, COULTER SN, NORRIS DA, HARLEY JB: Pattern of cutaneous immunoglobulin G deposits in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest 1989; 83: 1556-62.
35. CASCIOLA-ROSEN LA, ANHALT G, ROSEN A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-30.
36. GOLAN TD, ELKON KB, GHARAVI AE, KRUEGER JG: Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A radiation. J Clin Invest 1992; 90: 1067-76.
37. BENNION SD, NORRIS DA: Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE. Lupus 1997; 6: 181-92.